Name: Modeling the Effects of Hemodynamic Stress on Circulating Tumor Cells using a Syringe and Needle (Video) | JoVE Journal
Uploaded: 2021-04-27T14:30:00.000+00:00
Duration: 5 min 49 s
Description: Learn to model hemodynamic stress on circulating tumor cells using a syringe and needle system. This method applies brief fluid shear stress pulses to study cancer cell viability and mechanical resistance during metastasis.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

Development of the model demonstrated here was supported by DOD grant W81XWH-12-1-0163, NIH grants R21 CA179981 and R21 CA196202, and the Sato Metastasis Research Fund.

1. Cell preparation
<ol>
	<li>Release cells from tissue culture dish when 70-90% confluent by following the recommended guidelines for the cell line in use.
	<ol>
		<li>For example, aspirate the growth medium for PC-3 cells, and wash the 10 cm dish of cells with 5 mL of calcium- and magnesium-free phosphate-buffered saline (PBS).</li>
		<li>Aspirate the PBS before adding 1 mL of 0.25% trypsin using manufacturer&#39;s protocol.</li>
		<li>After observing the detachment of the cells under an inverted microscope, add 5 mL of DMEM:F12 medium containing 10% fetal bovine serum to inhibit the trypsin.</li>
	</ol>
	</li>
	<li>Place the cell suspension into a conical tube.</li>
	<li>Determine the cell concentration and total cell number.</li>
	<li>Pellet cells by centrifugation (300 &#215; g for 3 min), aspirate the supernatant, and resuspend cells in serum-free tissue culture medium to 5 &#215; 105 cells/mL. 
	&#8203;NOTE: It is critical that the assay medium contains at least 1.17 mM Ca++ as extracellular Ca++ has been demonstrated to be required for cellular resistance to FSS15.</li>
</ol>
2. Fluid shear stress exposure
<ol>
	<li>Prior to exposing cells to FSS, cut a round-bottom 14 mL polystyrene tube at the 7 mL line. Mix the cell suspension, place 5 mL of the suspension into the cut tube, and collect static control samples. 
	NOTE: The volume needed to collect for the static sample depends on the viability assay used (see step 3).</li>
	<li>Draw the cell suspension into a 5 mL syringe, and attach a 30 G &#189;&#34; needle. Uncap the needle, place the syringe onto a syringe pump, secure the syringe, and set the flow rate to achieve the desired level of FSS. 
	NOTE: Table 1 shows the maximum wall shear stress for different needles and flow rates, as well as the minimum level of FSS depending on cell size (10, 15, and 20 &#181;m). Inspect the needle prior to use to ensure that it is not bent; if uncertain, replace the needle with a new one. Needle integrity can have significant impact on the level of FSS applied.</li>
	<li>Run the syringe pump, and collect the sheared sample in the cut tube at an approximate 45&#176; angle to reduce foaming. Collect a sample depending on the type of viability assay or downstream assay needs.
	<ol>
		<li>Carefully remove the syringe and needle from the syringe pump, and use pliers to remove the needle from the syringe, taking care to not touch the needle. 
		NOTE: Non-beveled needles can be used interchangeably with beveled needles as an additional safety measure.</li>
	</ol>
	</li>
	<li>Draw the sheared suspension back into the syringe, carefully reattach the needle using pliers, and place it back into the syringe pump.</li>
	<li>Repeat steps 2.3 and 2.4 until the cell suspension has been exposed to the desired number of pulses of FSS. 
	&#8203;NOTE: To assess the capacity of cells to resist mechanical destruction from FSS exposure the cell suspension is typically subjected to 10 pulses of FSS. However, it has been demonstrated that cells start to undergo biological adaptations in response to FSS after 2 pulses24.</li>
</ol>
3. Viability measurement
NOTE: Viability can be assessed using enzymatic assays (luciferase, resazurin, and WST-1), counting intact cells, flow cytometry, or by clonogenic assays.
<ol>
	<li>For all measures of viability, collect a sample prior to exposing cells to FSS.
	<ol>
		<li>For enzymatic assays, take duplicate 100 &#181;L aliquots and place them into a 96-well plate.</li>
		<li>For flow cytometry, take one 500 &#181;L aliquot and place it into a 1.5 mL tube.</li>
		<li>For clonogenic assay, collect a 100 &#181;L aliquot.</li>
	</ol>
	</li>
	<li>Enzymatic assay
	<ol>
		<li>Collect 100 &#181;L samples after 1, 2, 4, 6, 8, and 10 pulses of FSS exposure and place them in a 96-well plate.</li>
		<li>Add the desired substrate, and follow the protocol for the assay used:
		<ol>
			<li>For resazurin, add 20 &#181;L of a 0.15 mg/mL solution to each well. Add 20 &#181;L of 0.15 mg/mL resazurin solution to wells containing 100 &#181;L of medium alone. Incubate for 2 h in a 37 &#176;C tissue culture incubator. Measure the absorbance using a plate reader capable of reading fluorescence (579 excitation/ 584 emission).</li>
			<li>For luciferase-expressing cells, add 100 &#181;L of 15 mg/mL D-luciferin to 5 mL of medium. Add 100 &#181;L of that solution to each well containing cells. Wait for 5 min, and then read the plate using a reader compatible with luminescence.</li>
			<li>For WST-1, add 10 &#181;L of WST-1 to each well, including wells containing medium only. Incubate for 4 h, and then read the absorbance between 420 and 480 nm using a plate reader.</li>
		</ol>
		</li>
		<li>Compare the averaged signal from each of the FSS-exposed samples to the averaged static control sample to obtain the percentage of viable cells.</li>
	</ol>
	</li>
	<li>Flow cytometry24
	<ol>
		<li>Collect 500 &#181;L samples and place them into 1.5 mL centrifuge tubes after 1, 2, 5, and 10 pulses of FSS.</li>
		<li>Centrifuge samples (500 &#215; g for 3 min), and discard the supernatants.</li>
		<li>Resuspend the pellets with 1 mL of calcium- and magnesium-free PBS, and centrifuge the samples (300 &#215; g for 3 min).</li>
		<li>Suspend the pellets with 500 &#181;L of fluorescence-activated cell sorting (FACS) buffer (PBS with 0.5% bovine serum albumin and 0.1% sodium&#160;azide) with counting beads and membrane-impermeable or viability dyes such as propidium iodide (1.75 &#181;g/mL).</li>
		<li>Determine the viability by comparing the ratio of viable cells, normalized to counting beads, in sheared samples to that of the static sample.</li>
	</ol>
	</li>
	<li>Clonogenic assay
	<ol>
		<li>Take 100 &#181;L of the static sample, and add 900 &#181;L of growth medium to make a 1:10 dilution.</li>
		<li>Take 100 &#181;L of the 1:10 diluted sample, and add 900 &#181;L of growth medium to make a final 1:100 dilution.</li>
		<li>Add 100 &#181;L of the 1:100 dilution sample into each of 3 wells of a 6-well dish containing 2 mL of growth medium.</li>
		<li>Repeat steps 3.4.1-3.4.3 with samples that have been subjected to 10 pulses of FSS.</li>
		<li>Let the cells grow for 7-10 days without changing the medium, and check for colony formation. Once colonies of &#8805;50 cells have formed, aspirate the growth medium, rinse each well with 1 mL of PBS, aspirate the PBS, and fix for 5 min using 1 mL of ice-cold 70% ethanol (EtOH). Importantly, fix both sheared and static samples at the same time</li>
		<li>After fixing the samples, aspirate the EtOH, and add 1 to 2 mL of crystal violet solution (0.1% crystal violet in 90% H2O, 10% EtOH) for 5 min.</li>
		<li>Rinse with an excess of water, and let the plate dry</li>
		<li>Count the colonies (clusters of &#8805;50 cells) for both the static and sheared samples. Compare the ratio of the average number of colonies from the sheared sample to the average number of colonies from the static sample to determine viability.</li>
	</ol>
	</li>
</ol>

<ol><li>Dillekås, H., Rogers, M. S., Straume, O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Are+90%25+of+deaths+from+cancer+caused+by+metastases%5BTitle%5D)+AND+%22Cancer+medicine%22%5BJournal%5D)">Are 90% of deaths from cancer caused by metastases.</a> Cancer medicine. 8 (12), 5574-5576 (2019).</li>
<li>Hanahan, D., Weinberg, R. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hallmarks+of+cancer%3A+the+next+generation%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Hallmarks of cancer: the next generation.</a> Cell. 144 (5), 646-674 (2011).</li>
<li>Strilic, B., Offermanns, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Intravascular+survival+and+extravasation+of+tumor+cells%5BTitle%5D)+AND+%22Cancer+Cell%22%5BJournal%5D)">Intravascular survival and extravasation of tumor cells.</a> Cancer Cell. 32 (3), 282-293 (2017).</li>
<li>Labelle, M., Hynes, R. O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+initial+hours+of+metastasis%3A+the+importance+of+cooperative+host-tumor+cell+interactions+during+hematogenous+dissemination%5BTitle%5D)+AND+%22Cancer+Discovery%22%5BJournal%5D)">The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination.</a> Cancer Discovery. 2 (12), 1091-1099 (2012).</li>
<li>Krog, B. L., Henry, M. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Biomechanics+of+the+circulating+tumor+cell+microenvironment%5BTitle%5D)+AND+%22Advances+in+Experimental+Medicine+and+Biology%22%5BJournal%5D)">Biomechanics of the circulating tumor cell microenvironment.</a> Advances in Experimental Medicine and Biology. 1092, 209-233 (2018).</li>
<li>Weiss, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Metastatic+inefficiency%5BTitle%5D)+AND+%22Advances+in+Cancer+Research%22%5BJournal%5D)">Metastatic inefficiency.</a> Advances in Cancer Research. 54, 159-211 (1990).</li>
<li>Zeidman, I., Mc, C. M., Coman, D. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Factors+affecting+the+number+of+tumor+metastases%3B+experiments+with+a+transplantable+mouse+tumor%5BTitle%5D)+AND+%22Cancer+Research%22%5BJournal%5D)">Factors affecting the number of tumor metastases; experiments with a transplantable mouse tumor.</a> Cancer Research. 10 (6), 357-359 (1950).</li>
<li>Fidler, I. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Metastasis%3A+quantitative+analysis+of+distribution+and+fate+of+tumor+embolilabeled+with+125+I-5-iodo-2%27-deoxyuridine%5BTitle%5D)+AND+%22Journal+of+the+National+Cancer+Institute%22%5BJournal%5D)">Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2'-deoxyuridine.</a> Journal of the National Cancer Institute. 45 (4), 773-782 (1970).</li>
<li>Cameron, M. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Temporal+progression+of+metastasis+in+lung%3A+cell+survival%2C+dormancy%2C+and+location+dependence+of+metastatic+inefficiency%5BTitle%5D)+AND+%22Cancer+Research%22%5BJournal%5D)">Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency.</a> Cancer Research. 60 (9), 2541-2546 (2000).</li>
<li>Luzzi, K. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Multistep+nature+of+metastatic+inefficiency%3A+dormancy+of+solitary+cells+after+successful+extravasation+and+limited+survival+of+early+micrometastases%5BTitle%5D)+AND+%22American+Journal+of+Pathology%22%5BJournal%5D)">Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.</a> American Journal of Pathology. 153 (3), 865-873 (1998).</li>
<li>Kienast, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Real-time+imaging+reveals+the+single+steps+of+brain+metastasis+formation%5BTitle%5D)+AND+%22Nature+Medicine%22%5BJournal%5D)">Real-time imaging reveals the single steps of brain metastasis formation.</a> Nature Medicine. 16 (1), 116-122 (2010).</li>
<li>Takagi, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Analysis+of+the+circulating+tumor+cell+capture+ability+of+a+slit+filter-based+method+in+comparison+to+a+selection-free+method+in+multiple+cancer+types%5BTitle%5D)+AND+%22International+journal+of+molecular+sciences%22%5BJournal%5D)">Analysis of the circulating tumor cell capture ability of a slit filter-based method in comparison to a selection-free method in multiple cancer types.</a> International journal of molecular sciences. 21 (23), 9031(2020).</li>
<li>Scott, J., Kuhn, P., Anderson, A. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Unifying+metastasis--integrating+intravasation%2C+circulation+and+end-organ+colonization%5BTitle%5D)+AND+%22Nature+Reviews+Cancer%22%5BJournal%5D)">Unifying metastasis--integrating intravasation, circulation and end-organ colonization.</a> Nature Reviews Cancer. 12 (7), 445-446 (2012).</li>
<li>Wirtz, D., Konstantopoulos, K., Searson, P. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+physics+of+cancer%3A+the+role+of+physical+interactions+and+mechanical+forces+in+metastasis%5BTitle%5D)+AND+%22Nature+Reviews+Cancer%22%5BJournal%5D)">The physics of cancer: the role of physical interactions and mechanical forces in metastasis.</a> Nature Reviews Cancer. 11 (7), 512-522 (2011).</li>
<li>Barnes, J. M., Nauseef, J. T., Henry, M. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Resistance+to+fluid+shear+stress+is+a+conserved+biophysical+property+of+malignant+cells%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Resistance to fluid shear stress is a conserved biophysical property of malignant cells.</a> PLoS One. 7 (12), 50973(2012).</li>
<li>Malek, A. M., Alper, S. L., Izumo, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hemodynamic+shear+stress+and+its+role+in+atherosclerosis%5BTitle%5D)+AND+%22JAMA%22%5BJournal%5D)">Hemodynamic shear stress and its role in atherosclerosis.</a> JAMA. 282 (21), 2035-2042 (1999).</li>
<li>Brass, L. F., Diamond, S. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Transport+physics+and+biorheology+in+the+setting+of+hemostasis+and+thrombosis%5BTitle%5D)+AND+%22Journal+of+Thrombosis+and+Haemostasis%22%5BJournal%5D)">Transport physics and biorheology in the setting of hemostasis and thrombosis.</a> Journal of Thrombosis and Haemostasis. 14 (5), 906-917 (2016).</li>
<li>Stein, P. D., Sabbah, H. N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Turbulent+blood+flow+in+the+ascending+aorta+of+humans+with+normal+and+diseased+aortic+valves%5BTitle%5D)+AND+%22Circulation+Research%22%5BJournal%5D)">Turbulent blood flow in the ascending aorta of humans with normal and diseased aortic valves.</a> Circulation Research. 39 (1), 58-65 (1976).</li>
<li>Strony, J., Beaudoin, A., Brands, D., Adelman, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Analysis+of+shear+stress+and+hemodynamic+factors+in+a+model+of+coronary+artery+stenosis+and+thrombosis%5BTitle%5D)+AND+%22The+American+Journal+of+Physiology%22%5BJournal%5D)">Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis.</a> The American Journal of Physiology. 265 (5), Pt 2 1787-1796 (1993).</li>
<li>Chalmers, J. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mixing%2C+aeration+and+cell+damage%2C+30%2B+years+later%3A+what+we+learned%2C+how+it+affected+the+cell+culture+industry+and+what+we+would+like+to+know+more+about%5BTitle%5D)+AND+%22Current+Opinion+in+Chemical+Engineering%22%5BJournal%5D)">Mixing, aeration and cell damage, 30+ years later: what we learned, how it affected the cell culture industry and what we would like to know more about.</a> Current Opinion in Chemical Engineering. 10, 94-102 (2015).</li>
<li>Vennin, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Trsient+tissue+priming+via+ROCK+inhibition+uncouples+pancreatic+cancer+progression%2C+sensitivity+to+chemotherapy%2C+and+metastasis%5BTitle%5D)+AND+%22Science+Translational+Medicine%22%5BJournal%5D)">Trsient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.</a> Science Translational Medicine. 9 (384), 126(2017).</li>
<li>Mitchell, M. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Lamin+A%2FC+deficiency+reduces+circulating+tumor+cell+resistance+to+fluid+shear+stress%5BTitle%5D)+AND+%22American+Journal+of+Physiology%3A+Cell+Physiology%22%5BJournal%5D)">Lamin A/C deficiency reduces circulating tumor cell resistance to fluid shear stress.</a> American Journal of Physiology: Cell Physiology. 309 (11), 736-746 (2015).</li>
<li>Ortiz-Otero, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cancer+associated+fibroblasts+confer+shear+resistance+to+circulating+tumor+cells+during+prostate+cancer+metastatic+progression%5BTitle%5D)+AND+%22Oncotarget%22%5BJournal%5D)">Cancer associated fibroblasts confer shear resistance to circulating tumor cells during prostate cancer metastatic progression.</a> Oncotarget. 11 (12), 1037-1050 (2020).</li>
<li>Moose, D. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cancer+cells+resist+mechanical+destruction+in+circulation+via+RhoA%2Factomyosin-dependent+mechano-adaptation%5BTitle%5D)+AND+%22Cell+Reports%22%5BJournal%5D)">Cancer cells resist mechanical destruction in circulation via RhoA/actomyosin-dependent mechano-adaptation.</a> Cell Reports. 30 (11), 3864-3874 (2020).</li>
<li>Miller, B. E., Miller, F. R., Wilburn, D. J., Heppner, G. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Analysis+of+tumour+cell+composition+in+tumours+composed+of+paired+mixtures+of+mammary+tumour+cell+lines%5BTitle%5D)+AND+%22British+Journal+of+Cancer%22%5BJournal%5D)">Analysis of tumour cell composition in tumours composed of paired mixtures of mammary tumour cell lines.</a> British Journal of Cancer. 56 (5), 561-569 (1987).</li>
<li>Aslakson, C. J., Miller, F. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Selective+events+in+the+metastatic+process+defined+by+analysis+of+the+sequential+dissemination+of+subpopulations+of+a+mouse+mammary+tumor%5BTitle%5D)+AND+%22Cancer+Research%22%5BJournal%5D)">Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.</a> Cancer Research. 52 (6), 1399(1992).</li>
<li>Chivukula, V. K., Krog, B. L., Nauseef, J. T., Henry, M. D., Vigmostad, S. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Alterations+in+cancer+cell+mechanical+properties+after+fluid+shear+stress+exposure%3A+a+micropipette+aspiration+study%5BTitle%5D)+AND+%22Cell+Health+Cytoskeleton%22%5BJournal%5D)">Alterations in cancer cell mechanical properties after fluid shear stress exposure: a micropipette aspiration study.</a> Cell Health Cytoskeleton. 7, 25-35 (2015).</li>
<li>Gensbittel, V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mechanical+adaptability+of+tumor+cells+in+metastasis%5BTitle%5D)+AND+%22Developmental+Cell%22%5BJournal%5D)">Mechanical adaptability of tumor cells in metastasis.</a> Developmental Cell. 56 (2), 164-179 (2021).</li>
<li>O'Leary, B. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pharmacological+ascorbate+inhibits+pancreatic+cancer+metastases+via+a+peroxide-mediated+mechanism%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism.</a> Scientific Reports. 10 (1), 17649(2020).</li>
<li>Williams, A. R., Hughes, D. E., Nyborg, W. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hemolysis+near+a+transversely+oscillating+wire%5BTitle%5D)+AND+%22Science%22%5BJournal%5D)">Hemolysis near a transversely oscillating wire.</a> Science. 169 (3948), 871-873 (1970).</li>
<li>Rooney, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hemolysis+near+an+ultrasonically+pulsating+gas+bubble%5BTitle%5D)+AND+%22Science%22%5BJournal%5D)">Hemolysis near an ultrasonically pulsating gas bubble.</a> Science. 169 (3948), 869-871 (1970).</li>
<li>Connolly, S., McGourty, K., Newport, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+in+vitro+inertial+positions+and+viability+of+cells+in+suspension+under+different+in+vivo+flow+conditions%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">The in vitro inertial positions and viability of cells in suspension under different in vivo flow conditions.</a> Scientific Reports. 10 (1), 1711(2020).</li>
<li>Brooks, D. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+biorheology+of+tumor+cells%5BTitle%5D)+AND+%22Biorheology%22%5BJournal%5D)">The biorheology of tumor cells.</a> Biorheology. 21 (1-2), 85-91 (1984).</li>
<li>Triantafillu, U. L., Park, S., Klaassen, N. L., Raddatz, A. D., Kim, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fluid+shear+stress+induces+cancer+stem+cell-like+phenotype+in+MCF7+breast+cancer+cell+line+without+inducing+epithelial+to+mesenchymal+transition%5BTitle%5D)+AND+%22Internation+Journal+of+Oncology%22%5BJournal%5D)">Fluid shear stress induces cancer stem cell-like phenotype in MCF7 breast cancer cell line without inducing epithelial to mesenchymal transition.</a> Internation Journal of Oncology. 50 (3), 993-1001 (2017).</li>
<li>Fan, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Circulatory+shear+flow+alters+the+viability+and+proliferation+of+circulating+colon+cancer+cells%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">Circulatory shear flow alters the viability and proliferation of circulating colon cancer cells.</a> Scientific Reports. 6, 27073(2016).</li>
<li>Fu, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((High+expression+of+MnSOD+promotes+survival+of+circulating+breast+cancer+cells+and+increases+their+resistance+to+doxorubicin%5BTitle%5D)+AND+%22Oncotarget%22%5BJournal%5D)">High expression of MnSOD promotes survival of circulating breast cancer cells and increases their resistance to doxorubicin.</a> Oncotarget. 7 (31), 50239-50257 (2016).</li>
<li>Li, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Shear+stress+promotes+anoikis+resistance+of+cancer+cells+via+caveolin-1-dependent+extrinsic+and+intrinsic+apoptotic+pathways%5BTitle%5D)+AND+%22Journal+of+Cellular+Physiology%22%5BJournal%5D)">Shear stress promotes anoikis resistance of cancer cells via caveolin-1-dependent extrinsic and intrinsic apoptotic pathways.</a> Journal of Cellular Physiology. 234 (4), 3730-3743 (2019).</li>
<li>Xin, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mechanics+and+actomyosin-dependent+survival%2Fchemoresistance+of+suspended+tumor+cells+in+shear+flow%5BTitle%5D)+AND+%22Biophysical+Journal%22%5BJournal%5D)">Mechanics and actomyosin-dependent survival/chemoresistance of suspended tumor cells in shear flow.</a> Biophysical Journal. 116 (10), 1803-1814 (2019).</li>
</ol>

MDH is a co-founder, President and shareholder of SynderBio, Inc. DLM is a consultant for SynderBio, Inc.

This paper demonstrates the application of FSS to cancer cells in suspension using a syringe and needle. Using this model, cancer cells have been shown to be more resistant to brief pulses of high-level FSS relative to non-transformed epithelial cells15,22,24. Furthermore, exposure to FSS using this model results in a rapid increase in cell stiffness, activation of RhoA, and increased cortical F-actin and myosin II-based contrac...

Metastasis, or the spread of cancer beyond the initial tumor site, is a major factor underlying cancer mortality1. During metastasis, cancer cells utilize the circulatory system as a highway to disseminate to distant sites throughout the body2,3. While en route to these sites, circulating tumor cells (CTCs) exist within a dynamic fluid microenvironment unlike that of their original primary tumor3,4,5. It has been proposed that this fluid microenvironment is one of many barriers to metastasis4. There is wide agreement in the concept of metastatic inefficiency, i.e., that most CTCs entering the circulation either perish or do not form productive metastatic colonies6,7,8. However, why metastasis is inefficient from the perspective of an individual CTC is less certain and remains an active area of investigation. CTCs are detached from extracellular matrix, deprived of soluble growth and survival factors that may be present in the primary tumor, and exposed to the immune system and hemodynamic forces in a much different manner than in the primary tumor4. Each of these factors may contribute to the poor survival of CTCs, but their relative contributions are unclear. This paper addresses the question of how hemodynamic forces affect CTCs.
Studying the effects of hemodynamic forces on CTCs is quite challenging. Currently, there are no engineered in vitro systems that can replicate the entire spatiotemporal dynamics (heart to capillaries) and rheological properties of the human vascular system. Moreover, how CTCs experience the circulatory system is not entirely clear. Experimental evidence indicates that most cancer cells do not circulate continuously like blood cells. Rather, due to their relatively large size (10-20 &#181;m in diameter), most CTCs become entrapped in capillary beds (6-8 &#181;m in diameter) for variable lengths of time (s to days) where they may die, extravasate, or be displaced to the next capillary bed8,9,10,11. However, there is some evidence that CTC size may be more heterogeneous in vivo, and that smaller CTCs are detectable12. Therefore, based on distance and blood flow velocity, CTCs may only circulate freely for a matter of seconds between these periods of entrapment, although a quantitative description of this behavior is lacking13.
Furthermore, depending on where CTCs enter the circulation, they may pass through multiple capillary beds in the lung and other peripheral sites and through both the right and left heart prior to reaching their final destination. Along the way, CTCs are exposed to various hemodynamic stresses including fluid shear stress (FSS), compressive forces during their entrapment in the microcirculation, and potentially, traction forces under circumstances where they might exhibit leukocyte-like rolling along blood vessel walls14. Thus, both the ability to model the circulation and the understanding of the CTC behavior to be modeled is limited. Because of this uncertainty, any findings from in vitro model systems should be validated in an experimental vertebrate organism and ultimately, in cancer patients.
With the aforementioned caveats, this paper demonstrates a relatively simple model to apply FSS to cells in suspension to probe the effects of FSS on CTCs first described in 201215. FSS results from friction of blood flow against the vessel wall, which produces a parabolic velocity gradient under conditions of laminar flow in larger vessels. Cells experience higher levels of FSS near vessel walls and lower levels near the center of the blood vessel. Fluid viscosity, flow rate, and dimensions of the conduit through which the flow occurs influence FSS, as described by the Hagen-Poiseuille equation. This applies to blood flows behaving as Newtonian fluids, but does not hold for the microcirculation. Physiological FSS ranges over several orders of magnitude with the lowest levels in the lymphatics (&#60;1 dyn/cm2) and the highest at regions around heart valves and atherosclerotic plaques (&#62;500 dyn/cm2)5. Mean wall shear stress in arteries is 10-70 dyn/cm2 and 1-6 dyn/cm2 in veins16,17.
In the heart, cells may be exposed to turbulent flows around valve leaflets where very high-level, but very short-duration FSS may be experienced18,19. Although the bioprocessing field has long studied the effects of FSS on mammalian cells in suspension, this information may be of limited value for understanding the effects of FSS on CTCs as it generally focuses on much lower levels of FSS applied over a long duration20. As described below, using a syringe and needle, one can apply relatively high (tens to thousands dyn/cm2) FSS for a relatively short (milliseconds) duration to a cell suspension. Since the initial description of this model15, others have employed it to study the effects of FSS on cancer cells21,22,23. Multiple &#34;pulses&#34; of FSS can be applied to cell suspensions in a short period of time to facilitate downstream experimental analyses. For example, this model can be used to measure the ability of cells to resist mechanical destruction by FSS by measuring cell viability as a function of the number of pulses applied. Alternatively, the effects of FSS exposure on the biology of cancer cells can be explored by collecting cells for a variety of downstream analyses. Importantly, part of the cell suspension is reserved as a static control to compare the effects of FSS from those that might be associated with cell detachment and time held in suspension.

<table><tbody><tr><td>0.25% Trypsin</td><td>Gibco</td><td>25200-056</td><td></td></tr><tr><td>14 mL round bottom tubes</td><td>Falcon - Corning</td><td>352059</td><td></td></tr><tr><td>30 G 1/2&quot; Needle</td><td>BD</td><td>305106</td><td></td></tr><tr><td>5 mL syringe</td><td>BD</td><td>309646</td><td></td></tr><tr><td>96-well black bottom plate</td><td>Costar - Corning</td><td>3915</td><td></td></tr><tr><td>Bioluminescence detector</td><td>AMI</td><td>AMI HTX</td><td></td></tr><tr><td>BSA, Fraction V</td><td>Sigma</td><td>10735086001</td><td></td></tr><tr><td>Cell Titer Blue</td><td>Promega</td><td>G8081</td><td></td></tr><tr><td>crystal violet</td><td>Sigma</td><td>C0775</td><td></td></tr><tr><td>D-luciferin</td><td>GoldBio</td><td>D-LUCK</td><td></td></tr><tr><td>DMEM</td><td>Gibco</td><td>11965-092</td><td></td></tr><tr><td>FBS</td><td>Atlanta Biologicals</td><td>S11150</td><td></td></tr><tr><td>PBS</td><td>Gibco</td><td>10010023</td><td></td></tr><tr><td>Plate Reader</td><td>BioTek</td><td>Synergy HT</td><td></td></tr><tr><td>Sodium Azide (NaN&lt;sub&gt;3&lt;/sub&gt;)</td><td>Sigma</td><td>S2002</td><td></td></tr><tr><td>Syringe Pump</td><td>Harvard Apparatus</td><td>70-3005</td><td></td></tr></tbody></table>

modeling the effects of hemodynamic stress on circulating tumor cells using a syringe and needle

Modeling the Effects of Hemodynamic Stress on Circulating Tumor Cells using a Syringe and Needle

During metastasis, cancer cells from solid tissues, including epithelia, gain access to the lymphatic and hematogenous circulation where they are exposed to mechanical stress due to hemodynamic flow. One of these stresses that circulating tumor cells (CTCs) experience is fluid shear stress (FSS). While cancer cells may experience low levels of FSS within the tumor due to interstitial flow, CTCs are exposed, without extracellular matrix attachment, to much greater levels of FSS. Physiologically, FSS ranges over 3-4 orders of magnitude, with low levels present in lymphatics (&#60;1 dyne/cm2) and the highest levels present briefly as cells pass through the heart and around heart valves (&#62;500 dynes/cm2). There are a few in vitro models designed to model different ranges of physiological shear stress over various time frames. This paper describes a model to investigate the consequences of brief (millisecond) pulses of high-level FSS on cancer cell biology using a simple syringe and needle system.

Elevated resistance to FSS-induced mechanical destruction has been previously shown to be a conserved phenotype across multiple cancer cell lines and cancer cells freshly isolated from tumors relative to non-transformed epithelial cell comparators15,24. Here, additional cancer cell lines from a variety of tissue origins (Table 2) were tested to demonstrate that the majority of these cells display viability ≥ 20% after 10 pulses of FSS at 250 µL/s...

Here we demonstrate a method to apply fluid shear stress to cancer cells in suspension to model the effects of hemodynamic stress on circulating tumor cells.

During metastasis, cancer cells from solid tissues, including epithelia, gain access to the lymphatic and hematogenous circulation where they are exposed ...

modeling-effects-hemodynamic-stress-on-circulating-tumor-cells-using

Research

JoVE Journal

Cancer Research

We present the procedure for fabrication and operation of a microfluidic device that recreates heterogeneous tumor microenvironments in vitro. The variability in apoptosis within tumor tissue was quantified using fluorescent stains and the effective diffusion coefficient of the chemotherapeutic drug doxorubicin into tumor tissue was evaluated.

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Source: Lim, M., et al. Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells. J. Vis. Exp. (2022)In this video, an anesthetized mouse undergoes a surgical procedure in which cancer cells are injected into the common carotid artery (CCA) to facilitate targeted delivery to the brain. The procedure involves precise suturing and manipulation of the carotid arteries to direct the injected cells toward the internal carotid artery (ICA), promoting tumor formation in the brain...

Modeling Brain Tumor Metastasis via Internal Carotid Artery Injection of Cancer Cells

We describe a matrigel plug assay to illustrate angiogenic potential of a pool of factors secreted by cancer cells using two complementary imaging modalities, ultrasound and endomicroscopy. The matrigel, an extracellular matrix (ECM)-mimic gel, is utilized to introduce the host (mouse) with angiogenic factors secreted to the conditioned media...

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

This manuscript describes the development of an animal model that allows for the direct testing of the effects of tumor hypoxia on metastasis and the deciphering the mechanisms of its action. Although the experiments described here focus on Ewing sarcoma, a similar approach can be applied to other tumor types.

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

A surgical procedure was developed to deliver mammary tumor cells to the murine liver via portal vein injection. This model permits investigation of late stages of liver metastasis in a fully immune competent host, including tumor cell extravasation, seeding, survival, and metastatic outgrowth in the liver.

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

We describe the establishment of orthotopic colorectal tumors via injection of tumor cells or organoids into the cecum of mice and the subsequent isolation of circulating tumor cells (CTCs) from this model.

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

In the age of immunotherapy and single-cell genomic profiling, cancer biology requires novel in vitro and computational tools for investigating the tumor-immune interface in a proper spatiotemporal context. We describe protocols to exploit tumor-immune microfluidic co-cultures in 2D and 3D settings, compatible with dynamic, multiparametric monitoring of cellular functions.

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Brain metastasis is a cause of severe morbidity and mortality in cancer patients. Most brain metastasis mouse models are complicated by systemic metastases confounding analysis of mortality and therapeutic intervention outcomes. Presented here is a protocol for internal carotid injection of cancer cells that produces consistent intracranial tumors with minimal systemic tumors.

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

This protocol presents a physiologically relevant tumor-on-a-chip model to perform high-throughput basic and translational human cancer research, advancing drug screening, disease modeling, and personalized medicine approaches with a description of loading, maintenance, and evaluation procedures.

Establishing a Physiologic Human Vascularized Micro-Tumor Model for Cancer Research

The article describes a protocol to simulate the transient temperature profiles and the coupled spatiotemporal variation of the interstitial fluid pressure following the heating delivered by a dipolar radiofrequency hyperthermia system. The protocol can be used to assess the response of biophysical parameters characterizing the tumor microenvironment to interventional hyperthermia techniques.

A Computational Modeling Approach to Investigate the Influence of Hyperthermia on the Tumor Microenvironment

Learn to model hemodynamic stress on circulating tumor cells using a syringe and needle system. This method applies brief fluid shear stress pulses to study cancer cell viability and mechanical resistance during metastasis.

Modeling the Effects of Hemodynamic Stress on Circulating Tumor Cells using a Syringe and Needle

Explore More Videos